Skip to main content

Table 4 univariate and multivariate survival analysis

From: Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

 Survivalp-value
 at 12 months (%)at 24 months (%)univariate Analysismultivariate Analysis
Age
  ≤ 65 years5619  
  > 65 years80270.676 
Gender
 Female8020  
 Male65230.629 
Karnofsky performance status
  > 80%7530  
  ≤ 80%55100.0410.077
UICC stage
 III6421  
 IV100330.537 
T category
 1–2670  
 3–468280.395 
N category
 0–1330  
 2–371250.299 
Histology
 Squamous cell carcinoma6925  
 Non- Squamous cell carcinoma67200.935 
Tobacco consumption (PY)
 07525  
 20–405012,50  
  > 4073270.758 
Grading
 Moderately differentiated5050  
 Poorly differentiated6719  
 anaplastic100500.758 
PD-L1 expression
 0%8629  
  ≥ 1%50190.0480.648
CD8+ TILs density
  ≤ 40%7040  
  > 40%61170.055 
TIME type
 I10060  
 II5020  
 III7114  
 IV40200.050.048